48North Cannabis Corp. Added to Horizons Emerging Marijuana Growers Index ETF TORONTO, Oct. 3, 2018 - 48North Cannabis Corp. ("48North" or the "Company") (TSXV:NRTH) today announced that the Company has been added to the Horizons Emerging Marijuana Growers Index ETF (NEO:HMJR). "The addition of 48North to the Horizons Emerging Marijuana Growers Index ETF is a validation of our strong position in the evolving cannabis industry and solidifies our place as an emerging player," said Alison Gordon, Chief Executive Officer at 48North. The Horizons Emerging Marijuana Growers Index ETF seeks to replicate, to the extent possible, the performance of the Emerging Marijuana Growers Index ("Index"), net of expenses. The Index is designed to provide exposure to the performance of a basket of primarily North American, publicly-listed, small-capitalization companies primarily involved in the cultivation, production and/or distribution of marijuana. Publicly listed companies within the Index should have a market capitalization greater than $50 million but less than $500 million for initial inclusion. About Horizons ETF

Horizons ETFs Management (Canada) Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs have more than $10 billion of assets under management and 83 ETFs listed on major Canadian stock exchanges. Horizons ETFs Management (Canada) Inc. is a member of the Mirae Asset Global Investments Group. About 48North

48North Cannabis Corp. ("48North") is a TSX Venture Exchange listed company whose wholly-owned subsidiary DelShen Therapeutics Corp. ("DelShen"), is a licensed producer of medical cannabis in Canada. 48North grows unique genetics sourced from MariPharm B.V., a Netherlands-based phytopharmaceutical company with over 25 years of experience in the research and cultivation of cannabis for medical purposes. Its genetics are grown to exacting standards, ensuring patients can count on receiving the highest-quality cannabis products. DelShen is regulated by the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") and received its license to produce cannabis on February 28, 2017, its cannabis sales license on June 25, 2018, and its extraction license to produce cannabis oil on September 13, 2018. DelShen's ACMPR licenses pertain to its state-of-the-art, closed-box, 40,000-square-foot facility located on 800-acres of owned land near Kirkland Lake, Ontario. DISCLAIMER & READER ADVISORY Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The business of the Company is subject to a number of material risks and uncertainties. Please refer to the Filing Statement and other SEDAR filings for further details. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the Company being able to obtain the necessary corporate, regulatory and other third parties approvals, and licensing and other risks associated with regulated ACMPR entities. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein. SOURCE 48North Cannabis Corp. For further information: Heidi Christensen Brown, 48North Investor Relations, (416) 848-1389, hchristensenbrown@national.ca; David Hackett, Chief Financial Officer, 48North, (416) 639-5891 ext 304, david@48nrth.com